In the News
-
May 19, 2017
New Report: PBMs Push Drug Costs
Drug Topics
A new review of studies on the economic impacts of pharmacy benefit managers (PBMs) found that they have an adverse impact on the overall costs and prices of drugs…Read More. -
May 15, 2017
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs
BioSpace
It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States…Read More. -
May 9, 2017
It’s Time to Switch Our Pharmacy Benefit Manager
Forbes
Express Scripts, the largest pharmacy benefit manager (PBM) in the nation, is discovering just how much customer service matters. It may also be discovering that suing your biggest customer in court is generally not considered good customer service…Read More. -
May 9, 2017
NEW BRIEF HIGHLIGHTS THE ECONOMIC COSTS OF PHARMACY BENEFIT MANAGERS
PRI
Exploring a tool that millions of Americans use every day when paying for prescription drugs, the Pacific Research Institute today released a new research brief exploring how Pharmacy Benefit Managers (PBMs) impact prescription drug costs, access, and patient care …Read More -
May 3, 2017
Long-term care pharmacy: missed opportunities
McKnight’s
One thing I’ve learned since joining this business years ago is that if you want a creative, persuasive thinker on your team, you could do a whole lot worse than Alan Rosenbloom…Read More -
Apr 4, 2017
To Improve Pharmaceutical Pricing, Reform PBMs And Fix Health Care’s Systemic Problems
Forbes
Accusations that pharmaceuticals are driving the problem of health care affordability abound. But, political misdiagnoses are just as problematic as medical misdiagnoses…Read More -
Mar 7, 2017
Reform Pharmacy Benefit Managers (PBMs) to improve pharmaceutical affordability
Forbes
After years of quietly gaining power, PBMs are coming under heightened public and congressional scrutiny. And, for good reasons…Read More -
Mar 3, 2017
PBMs Swimming Against Rising Tide of More Drug Pricing Transparency
Morning Consult
Amid the public uproar surrounding skyrocketing drug prices, Pharmacy Benefit Managers — the pharmaceutical industry’s primary middlemen — are attracting new scrutiny from key members of Congress increasingly disturbed by benefit managers’ complex array of surreptitious pricing practices and protocols…..Read More -
Feb 5, 2017
Winning the drug war
McKnight’s
If medication management is not at the very top of Debbie Meade’s list of most important issues, it is darn close. ….Read More
View Archives
By Date
- March 2024 (4)
- February 2024 (1)
- November 2023 (3)
- October 2023 (1)
- September 2023 (2)
- August 2023 (4)
- July 2023 (4)
- June 2023 (1)
- March 2023 (2)
- January 2023 (1)
- December 2022 (1)
- October 2022 (4)
- July 2022 (1)
- June 2022 (3)